from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv0385/-

LFCtreatmentdescriptionclass of inhibitor

-0.580

Amikacinug/mL Amikacintranslation

-0.827

Cap5-10ug/mL Capreomycintranslation

-0.884

Rox10-50 ug/mL Roxithromycintranslation

-0.260

SM2-5 ug/mL Streptomycintranslation

-0.806

Tet5-10 ug/mL Tetracyclinetranslation

-0.262

Rif0.2-5ug/mL Rifampicintranscription

-0.424

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.729

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.091

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.638

CPZ10-50 ug/mL Chlorpromazinerespiration

0.882

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.007

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.220

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.255

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.742

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.779

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.181

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.569

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.640

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.353

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.492

KCN5-20 ug/mL Potassium cyaniderespiration

-0.791

NaN30.2-2 mM Sodium aziderespiration

-0.721

Nigericin50 uM Nigericinrespiration

0.059

TRC10-150 ug/mL Triclosanrespiration

0.805

TRZ10-25 ug/mL Thioridazinerespiration

1.321

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

1.306

menadione6-10 ug/mL Menadionerespiration

0.384

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.505

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.277

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.480

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.306

NRP_1Non-replicating persistence stage 1dosRassociated

-0.668

Amp0.2mg/mL AmpicillincellWall

-0.011

Cephalexin20-100 ug/mL CephalexincellWall

-0.336

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.099

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.395

EMB10-20 ug/mL EthambutolcellWall

-0.138

Eta12-40 ug/mL EthionamidecellWall

0.015

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.129

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.457

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.311

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.395

BZA0.12 mg/mL BenzamidearomaticAmides

0.169

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.333

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.230

H2O24 mM hydrogen peroxideDNAdamaging

-0.074

Levo10 ug/mL LevofloxacinDNAdamaging

-0.850

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.594

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.195

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.753

UVUV-irradiationDNAdamaging

0.121

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.302

Antimycin12.5-50 ug/mL Antimycin A?

-0.235

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.311

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.337

PA_2110-50 ug/mL Antitubercular compound PA-21?

2.539

PA8240.2-2 ug/mL PA-824?

1.059

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.105

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.073

Verapamil50 uM Verapamil?

-0.448

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.089

methoxatin10-20 ug/mL Methoxatin?